Effect of Locally Administered Morphine and Bupivicaine on Acute and Chronic Postmastectomy Pain
CompletedPhase 2NCT02462577
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study investigate the effect of addition morphine to locally instillation bupivacaine on developing chronic neuropathic pain acute postoperative pain after breast cancer surgery and on the probability of developing chronic neuropathic pain.
Study details
- Official title
- Effect of Locally Administered Morphine and Bupivicaine on Acute and Chronic Postmastectomy Pain
- Conditions
- Interventions
- Drug: local instillation of morphine to surgical wound
- Sponsor
- Assiut University
- Start date
- 2015-01
- Primary completion
- 2015-08
- Sex
- Female
- Age range
- from 30 Years to 60 Years
- Results posted
- No results posted in this snapshot
- Countries
- Egypt
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * female patients with cancer breast scheduled for modified radical mastectomy with axillary dissection Exclusion Criteria: * allergy to the study drugs * significant cardiac, respiratory, renal or hepatic disease * drug or alcohol abuse * psychiatric illness that would interfere with perception and assessment of pain
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02462577